Predictors of long-term survival in patients with DLBCL/HGBCL following autoSCT

In this video, Daniel Landsburg, MD, University of Pennsylvania, Philadelphia, PA, discusses predictors of long-term survival following autologous stem cell transplantation (autoSCT) in patients with diffuse large B-cell lymphoma (DLBCL) and high grade B-cell lymphoma (HGBCL). Among other risk factors, Dr Landsburg discusses the outcomes seen in patients with a history of low grade B-cell lymphoma (LGBCL) or indolent B-cell lymphoma. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.